Central Nervous System (CNS) Drugs Market Research Report, Growth & Forecast

... and rising prevalence of lifestyle-associated CNS disorders are increasing global demand for CNS therapeutics. Mental health segment accounted for ... is expected to emerge as the fastest growing segment in the Central Nervous System therapeutics market. High demand for effective treatment and a large number ...

... manufacturers of Neuromyelitis Optica Drug, with price, sales, revenue and global market share of Neuromyelitis Optica Drug in 2017 and 2018. Chapter 3, the Neuromyelitis Optica Drug competitive situation, sales, revenue and global market share ...

This study covers the world outlook for CNS therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...

HNY Research projects that the Insomnia Pharmacological Treatment market size will grow from 3189.54 Million USD in 2025 to 3980.41 Million USD by 2031, at an estimated CAGR of 3.76%. The base year co...

HNY Research projects that the Myasthenia Gravis Drugs market size will grow from 1682.12 Million USD in 2025 to 2799.9 Million USD by 2031, at an estimated CAGR of 8.86%. The base year considered for...

HNY Research projects that the Tauopathies Treatment market size will grow from 968.43 Million USD in 2025 to 1719.05 Million USD by 2031, at an estimated CAGR of 10.04%. The base year considered for...

HNY Research projects that the Traumatic Brain Injury Therapeutics market size will grow from 1007.87 Million USD in 2025 to 1277.39 Million USD by 2031, at an estimated CAGR of 4.03%. The base year c...

The global Narcolepsy Drug market size is expected to reach $ 7492 million by 2032, rising at a market growth of 10.3% CAGR during the forecast period (2026-2032). Narcolepsy is a long-term neurologic...

The global Neuromyelitis Optica Drug market size is expected to reach $ 64.33 million by 2032, rising at a market growth of 2.9% CAGR during the forecast period (2026-2032). Neuromyelitis optica (NMO)...

The sleep disorder treatment market is forecasted to achieve a 10.23% CAGR, reaching USD 35.666 billion in 2031 from USD 19.878 billion in 2025. The sleep disorder treatment market is witnessing risin...

The Neurodegenerative Disease Therapeutics Market was valued at US$ 12.52 Billion in 2024 and is anticipated to reach US$ 28.78 Billion by 2033, at a CAGR of 0.098 from 2026 to 2032. The report delive...

According to Stratistics MRC, the Global Sensory Processing Disorder Tools Market is accounted for $2.20 billion in 2025 and is expected to reach $4.86 billion by 2032 growing at a CAGR of 12.0% durin...

According to Stratistics MRC, the Global Sleep Aids for Neurodivergent Market is accounted for $334.20 million in 2025 and is expected to reach $707.08 million by 2032 growing at a CAGR of 11.3% durin...

The Clinically Isolated Syndrome Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics,...

The Cluster Headache Market was valued at in and is anticipated to reach by , at a CAGR of 0.0755 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional...

The Migraine Nasal Spray Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional...

The Muscle Spasticity Market was valued at US$ 4.2 billion in 2022 and is anticipated to reach US$ 7.7 billion by 2030, at a CAGR of 0.081 from 2026 to 2032. The report delivers in-depth insights into...

The Opioid Use Disorder Drugs Market was valued at US$ 2.9 billion in 2022 and is anticipated to reach US$ 6.1 billion by 2030, at a CAGR of 0.101 from 2026 to 2032. The report delivers in-depth insig...

The Rare Neurological Disease Drugs Market was valued at US$ 139.4 billion in 2023 and is anticipated to reach US$ 269.7 billion by 2031, at a CAGR of 0.086 from 2026 to 2032. The report delivers in-d...

The Global Gabapentin Market, valued at USD 2.04 Billion in 2024, is projected to experience a CAGR of 5.60% to reach USD 2.83 Billion by 2030. Gabapentin, an anticonvulsant medication, is primarily u...

The Global Autism Spectrum Disorders Treatment Market, valued at USD 1.71 Billion in 2024, is projected to experience a CAGR of 5.39% to reach USD 2.34 Billion by 2030. The Global Autism Spectrum Diso...

The Acetylcholinesterase Inhibitors Market was valued at US$ 5.03 billion in 2023 and is anticipated to reach US$ 9.03 billion by 2031, at a CAGR of 0.078 from 2026 to 2032. The report delivers in-dep...

The Acute Migraine Drugs Market was valued at US$ 10.1 billion in 2022 and is anticipated to reach US$ 18.6 billion by 2030, at a CAGR of 0.081 from 2026 to 2032. The report delivers in-depth insights...

The Alcohol Use Disorder Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, includin...

The Anti-Suicide Drugs Market was valued at US$ 97.2 billion in 2023 and is anticipated to reach US$ 136.4 billion by 2031, at a CAGR of 0.045 from 2026 to 2032. The report delivers in-depth insights...

The Antidepressant Drugs Market was valued at US$ 14.3 billion in 2022 and is anticipated to reach US$ 20.6 billion by 2031, at a CAGR of 0.0556 from 2026 to 2032. The report delivers in-depth insight...

The Antiepileptic Drugs Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional...

The Dravet Syndrome Therapeutics Market was valued at in and is anticipated to reach by , at a CAGR of 0.115 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, includin...

The Drug-Resistant Epilepsy Market was valued at US$ 0.78 billion in 2022 and is anticipated to reach US$ 1.1 billion by 2030, at a CAGR of 0.044 from 2026 to 2032. The report delivers in-depth insigh...

The Dysthymia Drugs Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional grow...

The Edaravone Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional growth tre...

The Europe Acute Schizophrenia Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, in...

The Gamma-Aminobutyric Acid (GABA) Receptor Market was valued at in and is anticipated to reach by , at a CAGR of 0.045 from 2026 to 2032. The report delivers in-depth insights into key market dynamic...

The Infantile Spasm Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional grow...

The Insomnia Treatment Market was valued at US$ 3.7 billion in 2022 and is anticipated to reach US$ 5.1 billion by 2031, at a CAGR of 0.043 from 2026 to 2032. The report delivers in-depth insights int...

The Neurodegenerative Disease Market was valued at in and is anticipated to reach by , at a CAGR of 0.0745 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including...

The Neuromyelitis Optica (Devic's Syndrome) Market was valued at in and is anticipated to reach by , at a CAGR of 0.048 from 2026 to 2032. The report delivers in-depth insights into key market dynamic...

The Neuroprotection Market was valued at in and is anticipated to reach by , at a CAGR of 0.082 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional gr...

The Opioids Drug Market was valued at USD 39.2 billion in 2022 and is anticipated to reach by , at a CAGR of 0.033 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, in...

The Peripheral Neuropathy Market was valued at US$ 1,539 million in 2021 and is anticipated to reach by , at a CAGR of 0.042 from 2026 to 2032. The report delivers in-depth insights into key market dy...

The Post-Traumatic Stress Disorder Therapeutics Market was valued at US$ 2.36 billion in 2023 and is anticipated to reach US$ 3.96 billion by 2031, at a CAGR of 0.069 from 2026 to 2032. The report del...

The Postpartum Depression Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regiona...

The Pregabalin Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional growth tr...

The Progressive Supranuclear Palsy Therapeutics Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynam...

The Refractory Epilepsy Treatment Market was valued at US$ 3.97 billion in 2023 and is anticipated to reach US$ 5.78 billion by 2031, at a CAGR of 0.048 from 2026 to 2032. The report delivers in-depth...

The Refractory Status Drugs Epileptics Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, incl...

The Substance Abuse Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including reg...

The Tardive Dyskinesia Treatment Market was valued at in and is anticipated to reach by , at a CAGR of 0.04 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including...

The Tourette Syndrome Market was valued at in and is anticipated to reach by , at a CAGR of 0.105 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional...

The Traumatic Brain Injury Therapeutics Market was valued at in and is anticipated to reach by , at a CAGR of 0.049 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, i...